| Dr Emily Margaret Reilly, MD | |
|
4315 Diplomacy Dr, Anchorage, AK 99508-5926 | |
| (907) 729-4068 | |
| Not Available |
| Full Name | Dr Emily Margaret Reilly |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063916815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 175948 (Alaska) | Primary |
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
ZyGEM Corp. Ltd., has introduced its new microbial fingerprinting diagnostic technology that is expected to dramatically reduce the complexity and time needed to identify unknown infectious agents in mixed population samples. The approach is designed to run on the company's new MicroLab platform and has the potential to accurately identify up to 30 types of microbes simultaneously from a single sample in less than an hour.
The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there is still a need for antiviral therapies to protect health care workers and local populations in the event of future outbreaks.
Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
› Verified 1 days ago
| Entity Name | Southcentral Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
ZyGEM Corp. Ltd., has introduced its new microbial fingerprinting diagnostic technology that is expected to dramatically reduce the complexity and time needed to identify unknown infectious agents in mixed population samples. The approach is designed to run on the company's new MicroLab platform and has the potential to accurately identify up to 30 types of microbes simultaneously from a single sample in less than an hour.
The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there is still a need for antiviral therapies to protect health care workers and local populations in the event of future outbreaks.
Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily Margaret Reilly, MD 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: () - | Dr Emily Margaret Reilly, MD 4315 Diplomacy Dr, Anchorage, AK 99508-5926 Ph: (907) 729-4068 |
News Archive
ZyGEM Corp. Ltd., has introduced its new microbial fingerprinting diagnostic technology that is expected to dramatically reduce the complexity and time needed to identify unknown infectious agents in mixed population samples. The approach is designed to run on the company's new MicroLab platform and has the potential to accurately identify up to 30 types of microbes simultaneously from a single sample in less than an hour.
The recent Ebola outbreak in West Africa has claimed more than 11,300 lives and starkly revealed the lack of effective options for treating or preventing the disease. Progress has been made on developing vaccines, but there is still a need for antiviral therapies to protect health care workers and local populations in the event of future outbreaks.
Hi-Tech Pharmacal Co., Inc. today reported results for the third fiscal quarter ended January 31, 2014.
A research team at Washington University School of Medicine in St. Louis has identified potential new treatment targets for Alzheimer's disease, as well as existing drugs that have therapeutic potential against these targets.
› Verified 1 days ago
Elizabeth Mumford Galloway, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Anchorage, AK 99508 Phone: 907-562-2211 Fax: 509-479-0214 | |
Wendy Bailey, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3340 Providence Dr, Suite A-351, Anchorage, AK 99508 Phone: 907-212-4824 Fax: 907-212-4831 | |
Jay D. Johnson, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3801 Lake Otis Pkwy Ste 200, Anchorage, AK 99508 Phone: 907-212-6900 | |
Dr. Stephen Scott Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2841 Debarr Rd, Bldg A, Suite 23, Anchorage, AK 99508 Phone: 907-677-1864 Fax: 907-868-5167 | |
Dr. Rachel Mauryce Kerford Lescher, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4320 Diplomacy Dr, Suite 2300, Anchorage, AK 99508 Phone: 907-729-1000 Fax: 907-729-5244 | |
Dr. James Monroe Nesbitt Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3200 Providence Dr, Administration Office, Anchorage, AK 99508 Phone: 907-261-5098 Fax: 907-743-2358 |